## Abstract Serum and peripheral blood cell samples from eleven relatives of a T‐cell leukemia patient with human T‐cell leukemia/lymphoma virus (HTLV)‐associated disease, were investigated for the presence of HTLV antibody and antigen expression. In addition to the patient, three family members we
Location of human T-cell leukemia virus (HTLV) p19 antigen on virus-producing cells
✍ Scribed by Tadao Aoki; Chuya Hamada; Shigeko Ohno; Hideo Miyakoshi; Hiroko Koide; Marjorie Robert-Guroff; Robert C. Ting; Robert C. Gallo
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- French
- Weight
- 618 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Mouse monoclonal antibody to HTLV p19 was used to locate HTLV p19 on the surface of cells and virions by immunofluorescence microscopy (IFM) and immunoelectron microscopy (IEM). When HTLV-producing cells HUT 102 (B2 clone), MT-2 and strain A were used as target cells, HTLV p19 was detected on the surface of cells and virions as spots or small sectors by both IFM and IEM. Cells infected with animal type-C retroviruses, e.g., gibbon ape leukemia virus, simian sarcoma virus, feline leukemia virus, and Gross murine leukemia virus, were completely negative for HTLVp19 expression. Other human T cells not producing HTLV, including HUT78 and HSB2-0, immature or pre-T cells (Molt-3) derived from leukemia patients, and fresh peripheral blood T cells from healthy persons, were also negative. In addition, B cells including Rob-B, IM-9, Raji, and BT-1 did not react with the monoclonal antibody to HTLV p19. In the light of the presence of HTLV p19 in the periphery of acetone-fixed HTLV-producing cells as shown by IFM, it seems most likely that HTLV p19 is an internal antigen of HTLV with part of its structure protruding out of the viral and cell membrane. The monoclonal antibody to HTLV p19 did not lyse HTLV-producing cells in the presence of complement, as expected, because the antibody is an IgG1. Antibody-dependent cell-mediated cytotoxicity was also studied by the 51Cr-release assay. No cytotoxicity was observed. Although HTLV p19 does not contribute to the destruction of malignant T cells for treatment and/or virions for prophylaxis, this protein is an important marker for diagnosis of HTLV infection. The patterns of HTLV p19 expression described above were exactly the same for American HTLV-producing HUT 102 (B2 clone), for strain A cells and for Japanese HTLV-producing MT-2 cells. These results further substantiate the close relationship of the Japanese and American HTLV isolates.
📜 SIMILAR VOLUMES
## Abstract Human T‐cell leukemia/lymphoma virus (HTLV)‐producing cells were lysed by peripheral mononuclear cells (PMNC) from both anti‐HTLV antibody‐positive and ‐negative healthy persons in the presence of natural humoral antibodies against HTLV‐related antigens (antibody‐dependent cellular cyto
## Abstract Sera from patients with adult T‐cell leukemia (ATL) or other diseases and from healthy adults, whose titers of antibodies against ATL‐associated antigens (ATLA) had been determined by indirect immunofluorescence, were analysed by a procedure of immunoprecipitation followed by SDS‐polyac
## Abstract In order to clarify the cellular tropism of human T‐cell leukemia virus type I (HTLV‐I) and the effects of HTLV‐I infection on T‐cell functions, we investigated the infectiousness of HTLV‐I on T cells bearing T‐cell receptor (TCR) γδ and functional alterations of the HTLV‐I‐infected TCR
## Abstract In previous studies we detected retrovirus RD114 p30‐related antigen in human placental syncytiotrophoblasts and antibodies in cord blood sera. We now report that a monoclonal IgG antibody specific for the p19 protein of human T‐cell leukemia virus (HTLV) reacts with human syncytiotroph